NASDAQ:XAIR Beyond Air (XAIR) Stock Price, News & Analysis → top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad) Free XAIR Stock Alerts $1.18 -0.11 (-8.20%) (As of 05:13 PM ET) Add Compare Share Share Today's Range$1.13▼$1.2550-Day Range$1.19▼$2.0552-Week Range$1.13▼$6.36Volume503,805 shsAverage Volume309,960 shsMarket Capitalization$42.35 millionP/E RatioN/ADividend YieldN/APrice Target$11.25 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Get Beyond Air alerts: Email Address Beyond Air MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside853.3% Upside$11.25 Price TargetShort InterestBearish8.91% of Shares Sold ShortDividend StrengthN/ASustainability-0.91Upright™ Environmental ScoreNews SentimentN/AInsider TradingN/AProj. Earnings GrowthGrowingFrom ($1.93) to ($1.57) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.3.61 out of 5 starsMedical Sector334th out of 907 stocksSurgical & Medical Instruments Industry42nd out of 96 stocks 3.5 Analyst's Opinion Consensus RatingBeyond Air has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageBeyond Air has received no research coverage in the past 90 days. Previous Next 2.0 Short Interest Percentage of Shares Shorted8.91% of the outstanding shares of Beyond Air have been sold short.Short Interest Ratio / Days to CoverBeyond Air has a short interest ratio ("days to cover") of 10.5, which indicates bearish sentiment.Change versus previous monthShort interest in Beyond Air has recently decreased by 8.29%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldBeyond Air does not currently pay a dividend.Dividend GrowthBeyond Air does not have a long track record of dividend growth. Previous Next 3.5 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreBeyond Air has received a 41.63% net impact score from Upright. Beyond Air seems to create the most significant positive value in categories "Jobs", "Physical diseases", and "Creating knowledge". The positive contribution in the "Physical diseases" impact category is mostly driven by its "Medical ventilators", "Clinical research services for the respiratory system", and "Preclinical research services for physical health" products. See details.Environmental SustainabilityThe Environmental Impact score for Beyond Air is -0.91. Previous Next 1.1 News and Social Media Coverage Search Interest7 people have searched for XAIR on MarketBeat in the last 30 days. This is an increase of 75% compared to the previous 30 days.MarketBeat Follows5 people have added Beyond Air to their MarketBeat watchlist in the last 30 days. This is an increase of 150% compared to the previous 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Beyond Air insiders have not sold or bought any company stock.Percentage Held by Insiders19.00% of the stock of Beyond Air is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 31.50% of the stock of Beyond Air is held by institutions. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Beyond Air are expected to grow in the coming year, from ($1.93) to ($1.57) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Beyond Air is -0.55, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Beyond Air is -0.55, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioBeyond Air has a P/B Ratio of 0.84. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Stansberry ResearchWorld’s biggest multibillionaire investor is buying THIS by the ton [picture]Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.Click here to find out what to do. About Beyond Air Stock (NASDAQ:XAIR)Beyond Air, Inc. operates as a commercial-stage medical device and biopharmaceutical company in the United States. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired viral pneumonia, including COVID-19, as well as bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. is based in Garden City, New York.Read More XAIR Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart XAIR Stock News HeadlinesApril 10, 2024 | msn.comBeyond the Horizon Air and Space Show ends with record number of spectatorsMarch 20, 2024 | markets.businessinsider.comBeyond Air Prices Direct Offering Of $16 Mln Of Shares, WarrantsApril 25, 2024 | Traders Agency (Ad)top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.March 20, 2024 | globenewswire.comBeyond Air® Announces Pricing of $16.0 Million Registered Direct Offering of Common Stock and WarrantsMarch 16, 2024 | yahoo.comBeyond Paradise star teases a different side to her character in season 2February 23, 2024 | realmoney.thestreet.comWill Renewed Nvidia Excitement Lift the Entire Market?February 20, 2024 | yahoo.comBed Bath & Beyond has a new CEO, air quality’s rising impact on real estate and moreFebruary 13, 2024 | investing.comBeyond Air (XAIR) Earnings Dates & ReportsApril 25, 2024 | Traders Agency (Ad)top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.February 13, 2024 | msn.comBeyond Air, Inc. (NASDAQ:XAIR) Q3 2024 Earnings Call TranscriptFebruary 12, 2024 | benzinga.comRecap: Beyond Air Q3 EarningsFebruary 12, 2024 | msn.comBeyond Air, Inc. (XAIR) Reports Q3 Loss, Misses Revenue EstimatesFebruary 12, 2024 | finance.yahoo.comBeyond Air® Reports Financial Results for Third Quarter of Fiscal Year 2024February 12, 2024 | finance.yahoo.comBeyond Air® Reports Financial Results for Third Quarter of Fiscal Year 2024February 9, 2024 | benzinga.comA Preview Of Beyond Air's EarningsFebruary 3, 2024 | msn.comAI model gives air quality forecasts that are similar to weather forecastsJanuary 18, 2024 | finance.yahoo.comBeyond Air® Schedules Third Fiscal Quarter 2024 Financial Results Conference Call and WebcastDecember 27, 2023 | msn.comMedical Device Player Beyond Air's Subsidiary Reveals Encouraging Data From Early-Stage Cancer StudyDecember 27, 2023 | finance.yahoo.comBeyond Cancer™ Phase 1 Study Clears Cohort 1 in Patients with Advanced Relapsed or Refractory Unresectable Primary or Metastatic Cutaneous or Subcutaneous Solid TumorsDecember 23, 2023 | finance.yahoo.comBeyond Air Independent Director Acquires 102% More StockDecember 22, 2023 | benzinga.comBeyond Air Stock (NASDAQ:XAIR) Dividends: History, Yield and DatesDecember 22, 2023 | finance.yahoo.comDirector Robert Carey Acquires 1,200,000 Shares of Beyond Air Inc (XAIR)December 21, 2023 | msn.comBeyond Air CEO buys shares worth about $127k - filingDecember 21, 2023 | finance.yahoo.comInsider Buying: CEO Steven Lisi Acquires 77,775 Shares of Beyond Air IncDecember 19, 2023 | msn.comBeyond Air director Robert Carey purchases 1.2M common sharesNovember 29, 2023 | morningstar.comBeyond Air Inc XAIRNovember 15, 2023 | finance.yahoo.comBeyond Air® To Participate in the 35th Annual Piper Sandler Healthcare ConferenceSee More Headlines Receive XAIR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Beyond Air and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/12/2024Today4/25/2024Next Earnings (Estimated)6/27/2024Fiscal Year End3/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNASDAQ:XAIR CUSIPN/A CIK1641631 Webwww.beyondair.net Phone(516) 665-8200FaxN/AEmployees98Year FoundedN/APrice Target and Rating Average Stock Price Target$11.25 High Stock Price Target$15.00 Low Stock Price Target$10.00 Potential Upside/Downside+857.4%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)($2.13) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-55,820,000.00 Net MarginsN/A Pretax Margin-10,288.97% Return on Equity-199.90% Return on Assets-106.00% Debt Debt-to-Equity Ratio0.61 Current Ratio3.39 Quick Ratio3.26 Sales & Book Value Annual Sales$689,000.00 Price / Sales61.46 Cash FlowN/A Price / Cash FlowN/A Book Value$1.40 per share Price / Book0.84Miscellaneous Outstanding Shares36,039,000Free Float29,192,000Market Cap$42.35 million OptionableOptionable Beta-0.18 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesMr. Steven Adam Lisi (Age 53)CEO & Chairman of the Board Comp: $650kMr. Amir Avniel (Age 50)Co-Founder, President, Chief Business Officer & Director Comp: $400kMr. Michael A. Gaul (Age 69)Chief Operating Officer Comp: $350kMr. Douglas Quinton Larson (Age 53)CFO, Principal Financial Officer & Principal Accounting Officer Comp: $274.95kEdward BargerHead of Investor RelationsMs. Kori-Ann TaylorHead of MarketingDr. Andrew R. Colin M.D.Senior Medical Director Global Clinical Leadership & Member of Scientific Advisory BoardDr. Jeff Myers M.D. (Age 59)Ph.D., Chief Medical Officer Mr. Adam NewmanCorporate SecretaryMore ExecutivesKey CompetitorsDarioHealthNASDAQ:DRIOCarmellNASDAQ:CTCXApyx MedicalNASDAQ:APYXGBSNYSE:GBSInspireMDNYSE:NSPRView All CompetitorsInsiders & InstitutionsWealth Effects LLCSold 35,000 shares on 4/23/2024Ownership: 1.135%Gendell Jeffrey LBought 30,000 shares on 2/15/2024Ownership: 3.146%Simplex Trading LLCBought 6,100 shares on 2/2/2024Ownership: 0.000%Keel Point LLCBought 15,171 shares on 1/30/2024Ownership: 0.047%Wealth Effects LLCBought 96,150 shares on 1/29/2024Ownership: 1.389%View All Insider TransactionsView All Institutional Transactions XAIR Stock Analysis - Frequently Asked Questions Should I buy or sell Beyond Air stock right now? 3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Beyond Air in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" XAIR shares. View XAIR analyst ratings or view top-rated stocks. What is Beyond Air's stock price target for 2024? 3 Wall Street research analysts have issued 1 year target prices for Beyond Air's stock. Their XAIR share price targets range from $10.00 to $15.00. On average, they expect the company's share price to reach $11.25 in the next year. This suggests a possible upside of 853.3% from the stock's current price. View analysts price targets for XAIR or view top-rated stocks among Wall Street analysts. How have XAIR shares performed in 2024? Beyond Air's stock was trading at $1.96 at the beginning of the year. Since then, XAIR stock has decreased by 39.8% and is now trading at $1.1801. View the best growth stocks for 2024 here. Are investors shorting Beyond Air? Beyond Air saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 3,500,000 shares, an increase of 23.2% from the March 15th total of 2,840,000 shares. Based on an average daily volume of 299,900 shares, the days-to-cover ratio is currently 11.7 days. View Beyond Air's Short Interest. When is Beyond Air's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, June 27th 2024. View our XAIR earnings forecast. How were Beyond Air's earnings last quarter? Beyond Air, Inc. (NASDAQ:XAIR) released its quarterly earnings results on Monday, February, 12th. The company reported ($0.50) earnings per share for the quarter, beating the consensus estimate of ($0.61) by $0.11. The business had revenue of $0.39 million for the quarter, compared to analyst estimates of $0.49 million. During the same quarter in the previous year, the firm earned ($0.43) earnings per share. What guidance has Beyond Air issued on next quarter's earnings? Beyond Air issued an update on its FY 2025 earnings guidance on Tuesday, February, 13th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $12.0 million-$16.0 million. What other stocks do shareholders of Beyond Air own? Based on aggregate information from My MarketBeat watchlists, some companies that other Beyond Air investors own include OPKO Health (OPK), NVIDIA (NVDA), Pfizer (PFE), Axsome Therapeutics (AXSM), BioCryst Pharmaceuticals (BCRX), Enphase Energy (ENPH), General Motors (GM), Livongo Health (LVGO), Main Street Capital (MAIN) and Ollie's Bargain Outlet (OLLI). Who are Beyond Air's major shareholders? Beyond Air's stock is owned by a variety of retail and institutional investors. Top institutional investors include Wealth Effects LLC (1.13%). Insiders that own company stock include Amir Avniel, Douglas Beck, Erick Lucera, Michael A Gaul, Robert Carey, Ron Bentsur, Steven A Lisi and Yoori Lee. View institutional ownership trends. How do I buy shares of Beyond Air? Shares of XAIR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:XAIR) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyYour Money is Not SafeAmerican AlternativeThe only accurate crypto trading system I know …Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Beyond Air, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
